ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership230,072 shares
Latest Disclosed Value $ 5,121,402
Franklin Resources Inc reports 34.17% increase in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 230,072 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $5,121,403 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 171,483 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of 34.17% during the quarter. The current value of the position is $4,930,443 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 230,072 58,589 34.17 5,121 11.81 0.0002
2026-02-11 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 171,483 -207,001 -54.69 4,580 -34.63 0.0011
2025-11-13 2025-09-30 13F ABRDN ASIA PACIFIC INCOME FU COM NEW 004225108 378,484 223,243 143.80 7,007 109.26 0.0017
2025-08-12 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 155,241 -17,491 -10.13 3,349 16.70 0.0009
2025-05-13 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 172,732 -8,136 -4.50 2,869 -13.53 0.0008
2025-02-12 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 180,868 -8,097 -4.28 3,319 17.16 0.0009
2024-11-27 2024-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 188,965 -227 -0.12 2,833 -7.87 0.0008
2024-11-12 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 188,965 -227 2,833 0.0001
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 189,192 40,711 27.42 3,074 11.99 0.0009
2024-05-13 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 148,481 98,076 194.58 2,745 73.95 0.0009
2024-02-09 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 50,405 803 1.62 1,578 52.76 0.0007
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 49,602 2,198 4.64 1,034 -8.99 0.0005
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 47,404 16,578 53.78 1,135 95.69 0.0005
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 30,826 -505 -1.61 580 16.47 0.0003
2023-02-10 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 31,331 -436 -1.37 499 -4.23 0.0003
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 31,767 16,735 111.33 520 145.28 0.0003
2022-08-11 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,032 -3,084 -17.02 212 -51.71 0.0001
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,116 1,368 8.17 439 12.28 0.0002
2022-02-11 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 16,748 16,748 391 0.0001
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -711,711 -100.00 0 -100.00
2021-08-13 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 711,711 2,047 0.29 17,359 -5.19 0.0066
2021-05-13 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 709,664 -768 -0.11 18,309 -51.79 0.0074
2021-02-10 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 710,432 627 0.09 37,980 29.71 0.0161
2020-11-12 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 709,805 33,215 4.91 29,280 0.83 0.0142
2020-08-13 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 676,590 0 0.00 29,039 1.58 0.0150
2020-05-13 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 676,590 0 0.00 28,586 -1.24 0.0191
2020-03-11 2019-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 676,590 -73,200 -9.76 28,945 7.26 0.0152
2020-02-12 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 676,590 -73,200 28,945 15,292.3972
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 749,790 0 0.00 26,985 34.64 0.0147
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 749,790 0 0.00 20,042 -0.45 0.0107
2019-05-15 2019-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 749,790 719,396 2,366.90 20,132 4,000.20 0.0108
2019-05-14 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 749,790 719,396 20,132
2019-02-12 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 30,394 30,394 491 0.0003
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -2,166,346 -100.00 0 -100.00
2018-05-10 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,166,346 -1,071,500 -33.09 48,678 -50.07 0.0247
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,237,846 169,057 5.51 97,492 -15.67 0.0468
2017-11-13 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,068,789 -501,100 -14.04 115,601 16.11 0.0567
2017-08-10 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,569,889 -86,560 -2.37 99,563 -20.80 0.0496
2017-05-12 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,656,449 -565,340 -13.39 125,709 3.25 0.0638
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,221,789 46,003 1.10 121,756 -8.34 0.0630
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,175,786 809,100 24.03 132,832 21.55 0.0695
2016-08-11 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,366,686 778,269 30.07 109,283 51.00 0.0588
2016-05-10 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,588,417 760,484 41.60 72,372 11.06 0.0384
2016-04-27 2015-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 1,827,933 89,180 5.13 65,166 13.33 0.0330
2016-02-12 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,827,933 65,166
2015-11-10 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,738,753 -741,800 -29.90 57,501 -44.65 0.0284
2015-08-12 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,480,553 393,553 18.86 103,886 52.74 0.0472
2015-05-14 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,087,000 753,500 56.51 68,016 60.65 0.0308
2015-02-10 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,333,500 -148,900 -10.04 42,339 15.35 0.0192
2014-11-12 2014-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,482,400 -642,200 -30.23 36,704 -23.53 0.0167
2014-08-12 2014-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,124,600 879,800 70.68 47,995 58.47 0.0211
2014-05-13 2014-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,244,800 -121,000 -8.86 30,286 -11.27 0.0143
2014-02-12 2013-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,365,800 256,800 23.16 34,131 12.04 0.0167
2013-11-14 2013-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,109,000 148,800 15.50 30,464 74.80 0.0162
2013-08-09 2013-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 960,200 960,200 17,428 0.0099
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.